Citation Impact
Citing Papers
Effect of Long-term Propranolol Treatment on Hepatocellular Carcinoma Incidence in Patients with HCV-Associated Cirrhosis
2012
Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol
2012
Ascitic fluid pH in alcoholic cirrhosis: a reevaluation of its use in the diagnosis of spontaneous bacterial peritonitis.
1985
Results of portal decompression in patients with primary biliary cirrhosis.
1981
UK guidelines on the management of variceal haemorrhage in cirrhotic patients
2015
Improving prognosis following a first variceal haemorrhage over four decades
2001
Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy
2007
Reductions in 28-Day Mortality Following Hospital Admission for Upper Gastrointestinal Hemorrhage
2011 Standout
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial
2001
The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: A 12-year prospective cohort study
2015
Portosystemic Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt in Patients With Cirrhosis: Clinical, Laboratory, Psychometric, and Electroencephalographic Investigations
1998
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
2005 Standout
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Hepatocellular carcinoma
2018 Standout
A Model to Predict Survival in Patients With End–Stage Liver Disease
2001 Standout
Prevention of variceal rebleeding
2003
Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension
2009
Epidemiology of Severe Hospital‐Acquired Infections in Patients with Liver Cirrhosis: Effect of Long‐Term Administration of Norfloxacin
1998
Now there are many (stages) where before there was one
2009
Transfusion Strategies for Acute Upper Gastrointestinal Bleeding
2013 Standout
Beta-Blockers to Prevent Gastroesophageal Varices in Patients with Cirrhosis
2005
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
2003 Standout
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
1997 Standout
Burden of liver diseases in the world
2018 Standout
Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database
2006
Gene and other biological therapies for vascular diseases
1997
The Hemodynamic Response to Medical Treatment of Portal Hypertension As A Predictor of Clinical Effectiveness in the Primary Prophylaxis of Variceal Bleeding in Cirrhosis
2000
Predictors and Implications of Severe Hypersplenism in Patients with Cirrhosis
2003
Serum albumin and platelet count but not portal pressure are predictive of death in patients with Child-Pugh A hepatitis C virus-related cirrhosis
2005
Acute Hemodynamic Response to β-Blockers and Prediction of Long-term Outcome in Primary Prophylaxis of Variceal Bleeding
2009
Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: What is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?
2007
Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old
1996
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats
2013
Hepatocellular carcinoma
2012 Standout
Design and development of polymers for gene delivery
2005 Standout
Effect of cisapride on nocturnal transient lower oesophageal sphincter relaxations and nocturnal gastro‐oesophageal reflux in patients with oesophagitis: a double‐blind, placebo‐controlled study
2002
Hepatocellular carcinoma
2021 Standout
Optimization of ascitic fluid culture technique
1988
Pharmacological Reduction of Portal Pressure and Long-Term Risk of First Variceal Bleeding in Patients with Cirrhosis
2006
Asymptomatic bacterascites: Is it spontaneous bacterial peritonitis?
1991
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Helicobacter pylori infection and gastro-oesophageal reflux disease: coincidence or association?
2000
Hepatic Venous Pressure Gradient Predicts Clinical Decompensation in Patients With Compensated Cirrhosis
2007
Preventive effects of the heparin-coated stent on restenosis in the porcine model
1999
Carvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: A multicentre randomized controlled trial
2013
Is increased ammonia liberation after bleeding in the digestive tract the consequence of complete absence of isoleucine in hemoglobin? A study in pigs
1989
Selective intestinal decontamination prevents spontaneous bacterial peritonitis
1991
The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders
2007 Standout
Predictive models of short- and long-term survival in patients with nonbiliary cirrhosis
2003
Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy
2015
Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments
2015
Early primary prophylaxis with beta-blockers does not prevent the growth of small esophageal varices in cirrhosis: a randomized controlled trial
2012
Prevalence and prognostic significance of bacterascites in cirrhosis with ascites
1995
Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis: a randomised placebo-controlled trial
2016
Incidence and natural history of small esophageal varices in cirrhotic patients
2003
Lack of prognostic usefulness of hepatic venous pressures and hemodynamic values in a select group of patients with severe alcoholic cirrhosis
2002
Portal hypertension and variceal bleeding—Unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver single-topic conference
2008
Non invasive evaluation of portal hypertension using transient elastography
2011
Antioxidants and Atherosclerotic Heart Disease
1997 Standout
Epidemiology of gastro-oesophageal reflux disease: a systematic review
2005 Standout
Methods to study gastric emptying
1994
Incidence and mortality of carcinoids of the colon. Data from the connecticut tumor registry
1992
Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis
2007
Portal hypertensive bleeding in cirrhosis
2016 Standout
The Functional Gastrointestinal Disorders and the Rome III Process
2006 Standout
Recurrence of spontaneous bacterial peritonitis in cirrhosis: Frequency and predictive factors
1988
Ascitic fluid polymorphonuclear cell count and serum to ascites albumin gradient in the diagnosis of bacterial peritonitis
1990
Influence of Hepatic Venous Pressure Gradient on the Prediction of Survival of Patients With Cirrhosis in the MELD Era *
2005
Mechanisms of Hepatic Fibrogenesis
2008 Standout
A 5‐decade analysis of 13,715 carcinoid tumors
2003 Standout
Pathophysiological mechanisms for restenosis following coronary angioplasty: possible preventive alternatives
1993
Somatostatin Treatment and Risk Stratification by Continuous Portal Pressure Monitoring During Acute Variceal Bleeding
2001
Prevention of First Bleeding in Cirrhosis
1992
Patients Whose First Episode of Bleeding Occurs While Taking a β-Blocker Have High Long-term Risks of Rebleeding and Death
2012
Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding
2004
Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway
2005 Standout
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Liver stiffness measurement predicts severe portal hypertension in patients with HCV‐related cirrhosis†‡
2007
The effects of tegaserod (HTF 919) on oesophageal acid exposure in gastro‐oesophageal reflux disease
2000
Systematic review: proton‐pump inhibitor failure in gastro‐oesophageal reflux disease – where next?
2005
UK guidelines on the management of variceal haemorrhage in cirrhotic patients
2000
Helicobacter pyloriInfection
2002 Standout
Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document
2000 Standout
A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis
2004
A risk score to predict need for treatment for uppergastrointestinal haemorrhage
2000 Standout
Role of hiatus hernia and gastric mucosal atrophy in the development of reflux esophagitis in the elderly
2001
Epidemiology of hospital-acquired infections in cirrhotic patients: effect of carriage of methicillin-resistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis
2001
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Hospital care for low-risk patients with acute, nonvariceal upper GI hemorrhage: a comparison of neighboring community and tertiary care centers
2002
Clinical significance of variceal hemorrhage in recent years in patients with liver cirrhosis and esophageal varices
2004
Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices
1992
Clinical states of cirrhosis and competing risks
2017
Conflict of Interest in the Debate over Calcium-Channel Antagonists
1998 Standout
Prognostic value of early measurements of portal pressure in acute variceal bleeding
1999
Lovastatin plus probucol for prevention of restenosis after percutaneous transluminal coronary angioplasty
1996
Quantifying heterogeneity in a meta‐analysis
2002 Standout
A prospective study of bacterial infections in patients with cirrhosis
1993
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
Prognostic variables in patients with cirrhosis and oesophageal varices without prior bleeding
1994
The Value of Tumor Markers in Colorectal Cancer
1998
Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis
2007
The treatment of portal hypertension: A meta-analytic review
1995
The hepatic venous pressure gradient: Anything worth doing should be done right
2004
Colorectal cancer screening and surveillance: Clinical guidelines and rationale?Update based on new evidence
2003 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Cholesterol and mevalonic acid modulation in cell metabolism and multiplication
1992
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
Hepatocellular Carcinoma
2019 Standout
Improved method for bacteriological diagnosis of spontaneous bacterial peritonitis
1989
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Cost-Effectiveness of Colonoscopy in Screening for Colorectal Cancer
2000
Primary Biliary Cirrhosis
1987 Standout
Prokinetic agents for lower gastrointestinal motility disorders
1993
American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis
2004
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Systematic review with meta‐analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis
2014
Systematic Reviews: Synthesis of Best Evidence for Clinical Decisions
1997 Standout
Ascitic fluid pH and lactate: Insensitive and nonspecific tests in detecting ascitic fluid infection
1991
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Esophagitis and Gastroduodenal Disorders Associated With Diabetic Gastroparesis
1987
White Count, Ph and Lactate in Ascites in the Diagnosis of Spontaneous Bacterial Peritonitis
1985
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 Standout
G Protein Signaling and Vein Graft Intimal Hyperplasia
1998 StandoutNobel
Pharmacological Approaches to the Prevention of Restenosis After Coronary Angioplasty
1998
Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
2010 Standout
Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding
1999
Increase in ascites white blood cell and protein concentrations during diuresis in patients with chronic liver disease
1981
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
pH of ascitic fluid: Diagnostic and prognostic value in cirrhotic and noncirrhotic patients
1986
Portal Hypertension and Its Complications
2008
Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma
1999 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Hemodynamic Response to Pharmacological Treatment of Portal Hypertension and Long–Term Prognosis of Cirrhosis
2003
Spontaneous bacterial peritonis
1985
Hepatic Vein Pressure Gradient Reduction and Prevention of Variceal Bleeding in Cirrhosis: A Systematic Review
2006
Diabetic Autonomic Neuropathy
2003 Standout
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Immediate diagnostic criteria for bacterial infection of ascitic fluid
1986
Functional Significance of Cell Volume Regulatory Mechanisms
1998 Standout
Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis
2021
Spontaneous Bacterial Peritonitis: A Prospective Investigation in Predominantly Nonalcoholic Cirrhotic Patients
1983
Nonalcoholic Fatty Liver Disease
2015 Standout
Pathobiology of intimal hyperplasia
1994
Is the Acidity of Ascitic Fluid A Reliable Index in Making the Presumptive Diagnosis of Spontaneous Bacterial Peritonitis?
1986
Spontaneous Bacterial Peritonitis in Cirrhosis:Incidence, Diagnosis, and Prognosis
1987
SPONTANEOUS BACTERIAL PERITONITIS
1992
Ascitic Fluid Analysis in the Differentiation of Spontaneous Bacterial Peritonitis from Gastrointestinal Tract Perforation into Ascitic Fluid
1984
Works of Emanuel Lerner being referenced
Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: A 10-year prospective study
1996
Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage
1990
Effect of lovastatin on intimal hyperplasia after balloon angioplasty: A study in an atherosclerotic hypercholesterolemic rabbit
1991
Increasing incidence of cecal and sigmoid carcinoma: Data from the connecticut tumor registry
1990
Effect of portacaval anastomosis on hypersplenism
1980
The Diagnosis of Bacterial Peritonitis: Comparison of Ph, Lactate Concentration and Leukocyte Count
1985
Gastric emptying in patients with gastroesophageal reflux
1981
Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial
1991
Analysis of ascitic fluid in cirrhosis
1979
Portal-Systemic Encephalopathy and Portacaval Anastomosis: A Prospective, Controlled Investigation
1974
Predictors of Outcome in Massive Upper Gastrointestinal Hemorrhage
1986
The effect of lovastanin on intimal hyperplasia following balloon angioplasty: An angiographic and morphometric study of the artery in the atherosclerotic rabbit
1990
Effects of metoclopramide and bethanechol on delayed gastric emptying present in gastroesophageal reflux patients
1983